Early Access Programme
Terms and Conditions

1. Definitions

In these Terms the following words and expressions shall have the meanings set out below:

“IN7AI” / “we” / “us”

IN7AI Ltd, a company incorporated in England and Wales (Companies House No. 16010816).

“Software”

The IN7AI on-premise AI platform, including its Retrieval-Augmented Generation (RAG) engine, Small Language Model (SLM) components, and any associated tooling made available under this Programme.

“Early Access Programme”

The pre-commercial access scheme through which selected Participants may test and evaluate the Software prior to general release.

“Participant” / “you”

The individual professional or organisation that has been invited to join the Early Access Programme.

“Client Data”

Any data, documents, records, or information that you upload to, process through, or generate using the Software.

“On-Premise Deployment”

A configuration in which the Software runs exclusively on hardware under your control, with no network transmission of Client Data to IN7AI or any third party.

“Feedback”

Any suggestions, comments, bug reports, or other communications you provide to IN7AI regarding the Software.

“Confidential Information”

Any non-public technical, commercial, or operational information disclosed by either party in connection with this Programme.

2. Eligibility and Invitation

Participation in the Early Access Programme is by invitation only. Access is currently extended to licensed or regulated professionals in the following fields:

• Mental health and clinical psychology practitioners
• Psychiatrists, psychotherapists, and counsellors
• Social workers and safeguarding professionals
• Forensic assessment specialists
• Legal professionals handling sensitive client matters
• Defence and national security personnel (subject to additional vetting)
• Other regulated or confidentiality-sensitive professionals, at IN7AI's discretion

IN7AI reserves the right to decline or revoke access at its sole discretion, without liability, if a Participant is found to be ineligible or in breach of these Terms.

3. Data Privacy and On-Premise Architecture

3.1 Zero-Data-Exfiltration Commitment

The Software is designed and deployed as an On-Premise solution. IN7AI hereby warrants that, under normal operation:

• No Client Data is transmitted to IN7AI's servers or any third-party infrastructure.
• All RAG indexing and SLM inference occur exclusively on your local hardware.
• No telemetry, usage analytics, or diagnostic data containing Client Data is collected.
• There is no cloud dependency required for core functionality.

Your data never leaves your premises. This is a core architectural guarantee, not a policy choice.

3.2 Your Data Controller Responsibilities

As an On-Premise Deployment, you are the sole data controller for all Client Data processed through the Software. You are solely responsible for:

• Compliance with all applicable data protection legislation, including UK GDPR, the Data Protection Act 2018, and any sector-specific regulations (e.g. NHS DSP Toolkit, ICO guidance for mental health practitioners).
• Obtaining any required consent from your clients or patients before processing their data.
• Implementing appropriate access controls, encryption, and backup procedures on the hardware hosting the Software.
• Responding to any data subject access requests or regulatory enquiries relating to Client Data.

3.3 Limited Technical Diagnostics

Solely for the purpose of resolving technical issues, you may voluntarily share anonymised error logs with IN7AI via a separate, explicit action. Such sharing is always opt-in and will never include identifiable Client Data. IN7AI will process any such logs in accordance with its Privacy Policy.

4. Licence Grant

Subject to your compliance with these Terms, IN7AI grants you a limited, non-exclusive, non-transferable, revocable licence to install and use the Software solely for:

• Internal evaluation and testing within your professional practice or organisation.
• Live use with Client Data, subject to your data controller obligations in Clause 3.2.

This licence does not permit you to:

• Sub-licence, resell, or distribute the Software or any component thereof.
• Reverse-engineer, decompile, or attempt to extract source code.
• Use the Software to build a competing product or service.
• Remove or obscure any proprietary notices or branding.

5. Feedback and Improvement

We may invite you to provide Feedback during the Programme. You agree that:

• Any Feedback you provide is voluntary and you grant IN7AI a perpetual, royalty-free, worldwide licence to use it for product development and improvement.
• Feedback must not contain identifiable Client Data. Please anonymise all examples before sharing.
• Participation in optional feedback sessions (surveys, interviews, recorded calls) is entirely at your discretion.

6. Confidentiality

Each party agrees to keep the other’s Confidential Information strictly confidential and not to disclose it to any third party without prior written consent. This obligation does not apply to information that:

• Is or becomes publicly available through no fault of the receiving party.
• Was already known to the receiving party prior to disclosure.
• Is independently developed by the receiving party without reference to the Confidential Information.
• Must be disclosed by law, court order, or regulatory requirement — in which case the disclosing party shall give advance notice where lawfully permitted.

You agree not to publicly disclose the existence, content, or results of your evaluation without IN7AI’s prior written consent during the Programme period.

7. Acceptable Use

You agree to use the Software only for lawful purposes and in accordance with your professional obligations. You must not:

• Use the Software to process data without appropriate authorisation or consent.
• Attempt to circumvent security features or access controls.
• Use the Software to generate, store, or disseminate illegal, harmful, or abusive content.
• Use AI-generated outputs as a substitute for qualified professional judgement. The Software is designed to augment, not replace, human clinical or professional expertise.

Human-in-the-Loop Requirement

IN7AI is built on a human-in-the-loop architecture. All outputs must be reviewed and validated by a qualified professional before acting on them.

8. Disclaimers and Limitation of Liability

8.1 Early Access Disclaimer

The Software is provided during the Early Access Programme on an “as is” and “as available” basis. It has not yet been approved by the FCA, CQC, ICO, or any other regulatory body for clinical or professional deployment. It may contain bugs, errors, or incomplete features.

8.2 No Warranty

To the fullest extent permitted by law, IN7AI disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose, and non-infringement.

8.3 Limitation of Liability

IN7AI shall not be liable for any indirect, incidental, consequential, or punitive damages arising from your use of the Software. IN7AI’s total aggregate liability to you shall not exceed the total fees paid (if any) by you to IN7AI in the twelve months preceding the claim. Nothing in these Terms limits liability for death or personal injury caused by negligence, or for fraud.

9. Intellectual Property

All intellectual property rights in and to the Software, including the RAG architecture, SLM models, source code, documentation, and branding, are and shall remain the exclusive property of IN7AI Ltd. These Terms do not transfer any ownership rights to you.

You retain full ownership of all Client Data. IN7AI claims no rights over your data.

10. Term and Termination

The Early Access Programme begins on the date you activate your account and continues until terminated. Either party may terminate participation with seven (7) days’ written notice. IN7AI may suspend or terminate access immediately if:

• You breach any provision of these Terms.
• IN7AI discontinues the Early Access Programme.
• Continued access poses a security, legal, or reputational risk.

On termination, your licence to use the Software will cease immediately. Clauses 3, 6, 8, and 9 survive termination.

11. Governing Law and Disputes

These Terms are governed by and construed in accordance with the laws of England and Wales. Any dispute arising from or in connection with these Terms shall be subject to the exclusive jurisdiction of the courts of England and Wales.

Before commencing formal proceedings, both parties agree to attempt to resolve any dispute through good-faith discussions within thirty (30) days of written notice of the dispute.

12. General

• Entire Agreement: These Terms constitute the entire agreement between you and IN7AI regarding the Early Access Programme and supersede all prior discussions or representations.
• Amendments: IN7AI may update these Terms with fourteen (14) days’ notice. Continued use of the Software after the notice period constitutes acceptance.
• Severability: If any provision is found unenforceable, the remaining provisions continue in full force.
• No Waiver: Failure to enforce any provision does not constitute a waiver of that provision.
• Notices: Notices should be sent to info@in7ai.com or to your designated IN7AI contact.

Contact Us

IN7AI Ltd · Companies House No. 16010816
Email: info@in7ai.com
Website: www.in7ai.com

IN7AI Ltd — Version 1.0 — April 2026 — All Rights Reserved